AMH Level Indicating Ovarian Failure
Low AMH levels below 0.075-0.1 ng/mL indicate premature ovarian failure (POF), while levels below 0.83 ng/mL suggest premature ovarian insufficiency (POI), though AMH is not part of the formal diagnostic criteria for ovarian failure and should be interpreted alongside FSH and estradiol levels, particularly in women ≥25 years of age 1, 2.
Diagnostic Framework
The diagnosis of ovarian failure relies primarily on FSH elevation above 25-40 IU/L on two separate occasions at least one month apart, combined with low estradiol and clinical symptoms 1. AMH serves as a complementary marker rather than a standalone diagnostic criterion.
Specific AMH Thresholds by Clinical Category
For Premature Ovarian Failure (POF):
- AMH <0.075 ng/mL has 81.7% sensitivity and 94.4% specificity for POF diagnosis 2
- All POF patients show AMH levels below the 5th percentile of normoovulatory women 3
- Mean AMH in POF patients is approximately 0.04 ± 0.10 ng/mL 2
- 77% of POF patients with 0-5 follicles have undetectable AMH 4
For Premature Ovarian Insufficiency (POI):
- AMH <0.83 ng/mL has 95.8% sensitivity and 85.2% specificity for POI diagnosis 2
- Mean AMH in POI patients is approximately 0.69 ± 1.46 ng/mL 2
- 75% of women with incipient ovarian failure (regular cycles but elevated FSH) maintain normal AMH levels above the 5th percentile 3
Age-Specific Considerations
Critical caveat: AMH interpretation requires age-appropriate context 5. In women under 25 years, AMH shows significant fluctuations throughout the menstrual cycle and peaks around age 25 5. The guidelines specifically recommend exercising extra caution when interpreting AMH values before age 25 and state that validated normative data are only available for women ≥25 years 5.
For women under 25, low AMH does not reliably indicate reduced fertility or low ovarian reserve in the general population 5.
Clinical Algorithm for Interpretation
Step 1: Confirm appropriate clinical context
- Patient age ≥25 years for reliable AMH interpretation
- Not using hormonal contraception (which suppresses FSH and can mask diagnosis) 1
- Not during pre-ovulation peak (when estradiol would be 150-200 pg/mL per mature follicle) 1
Step 2: Integrate AMH with standard hormonal markers
- FSH >40 IU/L + AMH <0.075 ng/mL = POF (combined AUC approaches 1.0) 2
- FSH 25-40 IU/L + AMH <0.83 ng/mL = POI 2
- FSH >25 IU/L requires confirmation with repeat testing 1 month later 1
Step 3: Correlate with clinical presentation
- Amenorrhea or oligomenorrhea ≥4 months 1
- Vasomotor symptoms (hot flashes, night sweats) 1
- Low estradiol (<35 ng/mL in POF, variable in POI) 2
Important Clinical Pitfalls
AMH is NOT part of the formal diagnostic criteria for POI/POF 5. The diagnosis still requires elevated FSH and clinical symptoms. However, AMH provides valuable information about follicle pool status that FSH cannot capture, as FSH is a late marker of ovarian dysfunction 5.
Hormonal contraception interference: Women taking combined estrogen-progestin contraception or macro-progestins will have falsely low FSH levels. Discontinue antigonadotropic treatment for at least 3 months before reassessment 1.
AMH can identify residual follicular activity: In POF patients with detectable AMH (>0.1 ng/mL), there may be persistent follicles despite meeting clinical criteria for ovarian failure 4. 100% of patients with >15 AMH-immunopositive follicles had detectable serum AMH 4.
Correlation with Other Markers
AMH shows positive correlation with estradiol (r=0.291) and negative correlation with FSH (r=-0.476) 2. AMH changes significantly with age after 25 years, while inhibin B does not show age-related changes 3. AMH is more consistently correlated with clinical degree of follicle depletion than inhibin B or antral follicle count 3.